ASX:BDX BCAL Diagnostics (BDX) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free BDX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BCAL Diagnostics alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About BCAL Diagnostics Stock (ASX:BDX)BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. BDX Stock News HeadlinesFebruary 25, 2024 | benzinga.comSouthern Calif Bancorp Stock (NASDAQ:BCAL) Dividends: History, Yield and DatesJanuary 25, 2024 | msn.comBD (BDX) Collaborates With Hamilton to Benefit ResearchersApril 30, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.November 6, 2023 | morningstar.comSouthern Calif Bancorp BCALOctober 22, 2023 | finance.yahoo.comBCAL Diagnostics Limited (BDX.XA)October 12, 2023 | markets.businessinsider.comBecton Dickinson (BDX) Receives a Buy from DBSSeptember 14, 2023 | investing.comBCAL Diagnostics Ltd (BDX)August 23, 2023 | investing.comSouthern California Bancorp (BCAL)April 30, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.August 2, 2023 | msn.comIn Case You Missed It: Breast cancer test success and new scanner tech launched in US lottery ticketsAugust 2, 2023 | msn.comTop 10 at 10: AW1 makes big copper find in Canada; Breast cancer diagnostics test gets a liftAugust 2, 2023 | msn.comASX Health Stocks: PYC granted FDA Fast Track; BCAL announces breakthrough resultsAugust 2, 2023 | fool.com.au‘Breakthrough results’: Why this ASX healthcare share just exploded 160%June 6, 2023 | finance.yahoo.comBCAL Findings Presented at 2023 ASCO Annual MeetingMay 18, 2023 | msn.comBD's (BDX) New FDA Approval to Improve MRSA DiagnosticsApril 17, 2023 | seekingalpha.comBecton, Dickinson and Company: This Serial-Acquirer Is A BuyFebruary 26, 2023 | finance.yahoo.comBCAL Diagnostics First Half 2023 Earnings: AU$0.012 loss per share (vs AU$0.006 loss in 1H 2022)February 13, 2023 | reuters.comBDX.NJanuary 23, 2023 | finance.yahoo.comAlercell Is All Set to Launch a Leukemia Diagnostic Test Lena Q51(R)January 22, 2023 | finance.yahoo.comWorldwide Molecular Diagnostics for Infectious Disease Industry Report 2022: Developing World Driving ID Dx GrowthJanuary 17, 2023 | nasdaq.comBD's (BDX) New Robotic Track System to Boost Lab WorkflowOctober 4, 2022 | msn.comBD's (BDX) New Cloud Software Solution to Boost Lab WorkflowSeptember 25, 2022 | marketwatch.comIn Vitro Diagnostics (IVD) Quality Control Market 2022 Report Offers Key Futuristic Top Trends And Competitive Landscape By 2027September 5, 2022 | finance.yahoo.comBlood And Blood Components Global Market to Reach $44.11 Billion by 2026September 3, 2022 | finance.yahoo.comBCAL Diagnostics Limited (BDX.AX)August 9, 2022 | yahoo.comBD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with TreatmentsAugust 8, 2022 | finance.yahoo.comBD Announces Tender Offers for Outstanding Debt SecuritiesSee More Headlines Receive BDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BCAL Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:BDX CUSIPN/A CIKN/A Webwww.bd.com Phone12018476800FaxN/AEmployees72,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,000,000.00 Net Margins-134.82% Pretax MarginN/A Return on Equity-73.51% Return on Assets-34.87% Debt Debt-to-Equity Ratio24.77 Current Ratio5.21 Quick Ratio6.70 Sales & Book Value Annual Sales$3.71 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares252,300,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.21 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMs. Jayne Andrea ShawCo-Founder & Executive ChairmanDr. John G. Hurrell B.ScFulbright Fel, M.Sc(Qual), Ph.D., Chief Executive OfficerHon. Ronald Anthony Phillips A.O.Co-Founder & Non-Executive DirectorDr. Amani Batarseh Ph.D.Chief Scientist OfficerMr. Guy Adrian Robertson B.Com. (Age 71)B.Comm(Hons.), CA, MAICD, CFO & Company Secretary Mr. Shane Ryan M.B.A.Chief Operating OfficerSean KennedyDirector of Corporate FinanceMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1bioAffinity TechnologiesNASDAQ:BIAFWBiomark DiagnosticsCNSX:BUXView All CompetitorsInsidersMark BurrowsSold 300,000 sharesTotal: $30,000.00 ($0.10/share)Ronald (Ron) PhillipsBought 157,746 shares on 9/18/2023Total: $15,774.60 ($0.10/share)Merilyn SleighBought 45,000 shares on 5/2/2023Total: $4,095.00 ($0.09/share) This page (ASX:BDX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BCAL Diagnostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
